Company / PP&E (Net)
AbbVie PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$5.6B
FY2025
5-year range
$4.9B / $5.6B
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#7 of 195
Health Care
What the data says
Among 195 Health Care companies, AbbVie is in the top 4% for pp&e (net). PP&E (Net) has increased for 3 consecutive years, from $4.9B in FY2022 to $5.6B in FY2025.
Based on SEC 10-K filings.
$5.6B in FY2025 with a 5-year CAGR of +1.4%. Top quartile in the Health Care sector.
Improved from $5.0B to $5.6B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +1.4%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 195This company $5.6B Sector average $770.1M
▼
+630.8% above sector average
Key checks
Key Insights
- AbbVie's pp&e (net) has grown for 3 consecutive years.
- 5-year CAGR of +1.4%, indicating consistent growth.
- In FY2025, pp&e (net) increased 9.6% year-over-year.
- Ranks #7 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.6B | +9.6% |
| FY2024 | $5.1B | +2.9% |
| FY2023 | $5.0B | +1.1% |
| FY2022 | $4.9B | -3.4% |
| FY2021 | $5.1B | -2.6% |
| FY2020 | $5.2B | +77.2% |
| FY2019 | $3.0B | +2.7% |
| FY2018 | $2.9B | +2.9% |
| FY2017 | $2.8B | +7.6% |
| FY2016 | $2.6B | +1.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026